UA111462C2 - Use of (s)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate as active ingredient of pharmaceutical formulations intended for prevention and treatment of impaired vital functions of central nervous system in severe forms of ethanol intoxication - Google Patents

Use of (s)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate as active ingredient of pharmaceutical formulations intended for prevention and treatment of impaired vital functions of central nervous system in severe forms of ethanol intoxication

Info

Publication number
UA111462C2
UA111462C2 UAA201600367A UAA201600367A UA111462C2 UA 111462 C2 UA111462 C2 UA 111462C2 UA A201600367 A UAA201600367 A UA A201600367A UA A201600367 A UAA201600367 A UA A201600367A UA 111462 C2 UA111462 C2 UA 111462C2
Authority
UA
Ukraine
Prior art keywords
thioacetate
triazolyl
prevention
methyl
treatment
Prior art date
Application number
UAA201600367A
Other languages
Ukrainian (uk)
Inventor
Людмила Іванівна Кучеренко
Ігор Федорович Бєленічев
Іван Антонович Мазур
Іван Володимирович Павлюк
Олександр Сергійович Бідненко
Original Assignee
Товариство З Обмеженою Відповідальністю "Науково-Виробниче Об'Єднання "Фарматрон"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Товариство З Обмеженою Відповідальністю "Науково-Виробниче Об'Єднання "Фарматрон" filed Critical Товариство З Обмеженою Відповідальністю "Науково-Виробниче Об'Єднання "Фарматрон"
Priority to UAA201600367A priority Critical patent/UA111462C2/en
Publication of UA111462C2 publication Critical patent/UA111462C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Винахід належить до галузі медицини та фармацевтики і стосується застосування (S)-2,6-діаміногексанової кислоти 3-метил-1,2,4-триазоліл-5-тіоацетату як активної основи лікарських засобів для профілактики та лікування порушень життєзабезпечуючих функцій центральної нервової системи при важких формах гострого отруєння етанолом.FIELD: medicine, pharmaceutics. SUBSTANCE: invention relates to the use of (S) -2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate as an active drug base for the prevention and treatment of disorders of the central nervous system's vital functions. in severe forms of acute ethanol poisoning.

UAA201600367A 2016-01-16 2016-01-16 Use of (s)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate as active ingredient of pharmaceutical formulations intended for prevention and treatment of impaired vital functions of central nervous system in severe forms of ethanol intoxication UA111462C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201600367A UA111462C2 (en) 2016-01-16 2016-01-16 Use of (s)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate as active ingredient of pharmaceutical formulations intended for prevention and treatment of impaired vital functions of central nervous system in severe forms of ethanol intoxication

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201600367A UA111462C2 (en) 2016-01-16 2016-01-16 Use of (s)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate as active ingredient of pharmaceutical formulations intended for prevention and treatment of impaired vital functions of central nervous system in severe forms of ethanol intoxication

Publications (1)

Publication Number Publication Date
UA111462C2 true UA111462C2 (en) 2016-04-25

Family

ID=55861420

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201600367A UA111462C2 (en) 2016-01-16 2016-01-16 Use of (s)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate as active ingredient of pharmaceutical formulations intended for prevention and treatment of impaired vital functions of central nervous system in severe forms of ethanol intoxication

Country Status (1)

Country Link
UA (1) UA111462C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2679447C1 (en) * 2018-02-13 2019-02-11 Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон" Application of l-lysine tiazototate as an active basis for medicines of hepatoprotective and detoxicative action

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2679447C1 (en) * 2018-02-13 2019-02-11 Общество С Ограниченной Ответственностью "Научно-Производственное Объединение "Фарматрон" Application of l-lysine tiazototate as an active basis for medicines of hepatoprotective and detoxicative action

Similar Documents

Publication Publication Date Title
EA201800064A1 (en) 1,1,1-TRIFTOR-3-HYDROXYPROPAN-2-IL CARBAMATE DERIVATIVES AND 1,1,1-TRIFTOR-4-HYDROXYBUTAN-2-IL CARBAMATE DERIVATIVES AS MIGL INHIBITORS
BR112018073663A2 (en) Spiro-lactam nmda receptor modulators and their uses
EA202090573A1 (en) COMPOSITIONS OF NIRAPARIBA
BR112019001768A2 (en) spiro-lactam receptor modulators and their uses
BR112015010663A8 (en) sustained release oral dosage forms, and use of ruxolitinib or a pharmaceutically acceptable salt thereof
EA201100032A1 (en) PYRIDINE COMPOUNDS
EA201992162A1 (en) COMPOSITIONS BASED ON NIRAPARIB
BR112015018087A8 (en) compound, pharmaceutical composition and use
EA201991374A1 (en) WATER-SOLUBLE DERIVATIVE OF EPIALLOPRANANOLONE AND ITS APPLICATION
BR112015030315A2 (en) 4-alkynylimidazole derivative and medicament comprising the same as active ingredient
EA202091020A1 (en) SUBSTITUTED IMIDAZOPYRIDINAMIDES AND THEIR APPLICATION
MY191980A (en) Formulations containing an extract of echinacea and linoleic acid derivatives
EA201590797A1 (en) PREPARATIONS WITH THE MODIFIED PROBE RELEASE
TR201821157T4 (en) ORAL APPLICATION SOLID COMPOSITION CONTAINING IBANDRONIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT AND VITAMIN D.
MX2017013636A (en) Tamper-resistant fixed dose combination providing fast release of two drugs from different particles.
EA202191684A1 (en) DRUG CONTAINING URSODEOXYCHOLIC ACID FOR TREATMENT OR PREVENTION OF PRESBIOPIA
MX2021008536A (en) Modified release tablet formulations containing phosphodiesterase inhibitors.
BR112018073419A2 (en) combination, use of combination, method for treatment, compound, method for treatment of alzheimer's disease and pharmaceutical composition
WO2018033941A3 (en) Pharmaceutical compositions of ibrutinib
UA111462C2 (en) Use of (s)-2,6-diaminohexanoic acid 3-methyl-1,2,4-triazolyl-5-thioacetate as active ingredient of pharmaceutical formulations intended for prevention and treatment of impaired vital functions of central nervous system in severe forms of ethanol intoxication
WO2016191458A3 (en) Pharmaceutical compositions affecting mitochondrial redox state and methods of treatment
EA201991817A1 (en) Intranasal Composition Including Betagistin
EA202190317A1 (en) DRUG FOR EXTERNAL USE
EA201990550A1 (en) OPHTHALMIC DRUG INCLUDING THE ASOLIC COMPOUND
WO2017205779A3 (en) Compositions and methods for treating disorders related to inflammasome activity and il-1alpha expression